Why did FDA gene therapy regulators get forced out?
How are tariffs boosting used car sales?
Why is Meta launching $399 smart glasses now?
How is Fed rate cut talk affecting markets?
Why did Darden Restaurants raise sales forecast?
What impact is Israel-Iran conflict having on markets?
Why is JPMorgan adding bond trading to its app?
How KalVista Pharma Is Taking On A Rare But Deadly Disease
investors.com/news/technology/kalvista-biotech-stock-hereditary-angioedema-treatment
Biotech stock KalVista has soared recently, as the firm looks to fundamentally change the treatment landscape for HAE patients.
The post How KalVista Pharma Is Taking On A Rare But Deadly Disease appeared first on Investor's Business Daily.
This story appeared on investors.com, 2025-06-20 12:02:51.